Infectious Diseases Center Recognizes its 20th Anniversary and World AIDS Day
CINCINNATIThe Infectious Diseases Center (IDC), a partnership between the University of Cincinnati, University Hospital and the Health Alliance, will recognize its 20th anniversary and World AIDS Day with a commemorative program on Friday, Dec. 1.
The event will take place from 3 to 4:30 p.m. in the
The program will commemorate the
Former Cincinnati broadcasting celebrity Nick Clooney will emcee the program, which will be attended by representatives from Cincinnati mayor Mark Mallorys office as well as patients, physicians and staff from the Infectious Diseases Center and representatives from UC, University Hospital, the Health Alliance and other community organizations.
Since its inception in January 1986, the
The HIV/AIDS epidemic is not going away, says Carl Fichtenbaum, MD, medical director of the center. The number of newly diagnosed persons with HIV remains steady each year in
We need continuous funding to build upon these accomplishments and continue the fight against AIDS in
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.